R. Poledne
Impact in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
-
- Cardiovascular Disease and Adiposity
- Lipid metabolism and disorders
Papers in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 25
- Diet, Metabolism, and Disease 17
-
- Cardiovascular Disease and Adiposity 23
- Co-authors
- Jaroslav A. HubáčekJan PiťhaIvana Králová LesnáZdena ŠkodováJ. KovářVěra AdámkováVladimír StaněkP. Stávek
- Journals
- Physiological Research (35 papers)Atherosclerosis (11 papers)Atherosclerosis Supplements (11 papers)Clinical Genetics (4 papers)Metabolism (4 papers)
- Partner nations
- CzechiaRussiaUnited Kingdom
In The Last Decade
R. Poledne
196 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 125
- Endocrinology, Diabetes and Metabolism 654
- Cardiology and Cardiovascular Medicine 676
- Biological Psychiatry 51
- Immunology 421
- Epidemiology 689
Countries citing papers authored by R. Poledne
This map shows the geographic impact of R. Poledne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Poledne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Poledne more than expected).
Fields of papers citing papers by R. Poledne
This network shows the impact of papers produced by R. Poledne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Poledne. The network helps show where R. Poledne may publish in the future.
Co-authors
The 25 scholars most cited alongside R. Poledne, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 6 | |
| 3 | 2023 | 1 | |
| 4 | 2019 | 4 | |
| 5 | The association between subclinical atherosclerosis in carotid arteries and Connexin 37 gene polymorphism (1019C>T; Pro319Ser) in women. | 2011 | 6 |
| 6 | 2010 | 1 | |
| 7 | 2009 | 12 | |
| 8 | 2007 | 11 | |
| 9 | 2007 | 20 | |
| 10 | 2006 | 1 | |
| 11 | 2006 | 0 | |
| 12 | 2006 | 78 | |
| 13 | 2004 | 23 | |
| 14 | 2003 | 16 | |
| 15 | 2001 | 8 | |
| 16 | [Longitudinal trends of total and HDL cholesterol in a representative population sample in the Czech Republic]. | 2000 | 3 |
| 17 | Changes in cigarette smoking in the adult population of six districts of the Czech Republic over the 1985-92 period | 1996 | 1 |
| 18 | 1996 | 1 | |
| 19 | [Arteriosclerosis risk factors in the offspring and siblings of type 2 diabetics]. | 1991 | 2 |
| 20 | The metabolism of 1-14-C-tripalmitate in rat liver. | 1966 | 1 |
About R. Poledne
R. Poledne is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, Cancer Research, Epidemiology and Surgery, having authored 205 papers that have together received 2.9k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (43 papers), Adipokines, Inflammation, and Metabolic Diseases (41 papers), Cancer, Lipids, and Metabolism (33 papers), Cholesterol and Lipid Metabolism (26 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (25 papers), Cardiovascular Disease and Adiposity (23 papers), Liver Disease Diagnosis and Treatment (18 papers) and Diet, Metabolism, and Disease (17 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (654 citations), Cardiology and Cardiovascular Medicine (676 citations), Biological Psychiatry (51 citations), Immunology (421 citations) and Epidemiology (689 citations). R. Poledne has collaborated with scholars based in Czechia, Russia and United Kingdom. Frequent co-authors include Jaroslav A. Hubáček, Jan Piťha, Ivana Králová Lesná, Zdena Škodová, J. Kovář, Věra Adámková, Vladimír Staněk, P. Stávek, Pavel Suchánek and Soňa Čejková. Their work appears in journals such as Physiological Research, Atherosclerosis, Atherosclerosis Supplements, Clinical Genetics and Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.